Automated Bright-Field Dual Color, Dual Hapten HER2 In Situ Hybridization (DISH) Assay: An Alternative Method for Evaluation of HER2 Gene Amplification in Breast Cancer

被引：0
|
作者：
Tafe, L. J.
Teruya-Feldstein, J.
McElhinny, A.
Ranger-Moore, J.
Einch, J.
Schemp, C.
Barbashina, V.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Ventana Med Syst Inc, Tucson, AZ USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
324
引用
收藏
页码：74A / 74A
页数：1
相关论文
共 50 条
  • [1] Automated Bright-Field Dual Color, Dual Hapten HER2 In Situ Hybridization (DISH) Assay: An Alternative Method for Evaluation of HER2 Gene Amplification in Breast Cancer
    Tafe, L. J.
    Teruya-Feldstein, J.
    McElhinny, A.
    Ranger-Moore, J.
    Emch, J.
    Schemp, C.
    Barbashina, V.
    MODERN PATHOLOGY, 2010, 23 : 74A - 74A
  • [2] Are We Ready for Implementation of Bright-Field HER2 Dual In Situ Hybridization (DISH) Assay in Routine HER2 Testing?
    Chivukula, Mamatha
    Metkus, Andrea
    Brown, Jennifer
    Borofsky, Harriet
    Cuff, Justin
    Bulusu, Gautam
    Duncan, Keith
    MODERN PATHOLOGY, 2015, 28 : 38A - 38A
  • [3] Are We Ready for Implementation of Bright-Field HER2 Dual In Situ Hybridization (DISH) Assay in Routine HER2 Testing?
    Chivukula, Mamatha
    Metkus, Andrea
    Brown, Jennifer
    Borofsky, Harriet
    Cuff, Justin
    Bulusu, Gautam
    Duncan, Keith
    LABORATORY INVESTIGATION, 2015, 95 : 38A - 38A
  • [4] Dual-Color In Situ Hybridization (Dual ISH) for Evaluation of HER2/Neu (HER2) Amplification in Breast Cancer
    Astvatsaturyan, K.
    Bose, S.
    MODERN PATHOLOGY, 2013, 26 : 28A - 28A
  • [5] Dual-Color In Situ Hybridization (Dual ISH) for Evaluation of HER2/Neu (HER2) Amplification in Breast Cancer
    Astvatsaturyan, K.
    Bose, S.
    LABORATORY INVESTIGATION, 2013, 93 : 28A - 28A
  • [6] Bright-field HER2 dual in situ hybridization (DISH) assay on breast cancer cell blocks: a comparative study with histological sections
    Rieko Nishimura
    Nami Okamoto
    Masakazu Satou
    Kenta Kojima
    Shinichi Tanaka
    Natsumi Yamashita
    Breast Cancer, 2016, 23 : 917 - 921
  • [7] Bright-field HER2 dual in situ hybridization (DISH) assay on breast cancer cell blocks: a comparative study with histological sections
    Nishimura, Rieko
    Okamoto, Nami
    Satou, Masakazu
    Kojima, Kenta
    Tanaka, Shinichi
    Yamashita, Natsumi
    BREAST CANCER, 2016, 23 (06) : 917 - 921
  • [8] Characterization of HER2 gene amplification heterogeneity in invasive and in situ breast cancer using bright-field in situ hybridization
    António Polónia
    Guilherme Oliveira
    Fernando Schmitt
    Virchows Archiv, 2017, 471 : 589 - 598
  • [9] Characterization of HER2 gene amplification heterogeneity in invasive and in situ breast cancer using bright-field in situ hybridization
    Polonia, Antonio
    Oliveira, Guilherme
    Schmitt, Fernando
    VIRCHOWS ARCHIV, 2017, 471 (05) : 589 - 598
  • [10] Bright-Field HER2 Dual In Situ Hybridization (DISH) Assay vs Fluorescence In Situ Hybridization (FISH) Focused Study of Immunohistochemical 2+Cases
    Gao, Faye F.
    Dabbs, David J.
    Cooper, Kristine L.
    Bhargava, Rohit
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 141 (01) : 102 - 110
12345